143 related articles for article (PubMed ID: 21204590)
1. Estimated cost savings associated with the transfer of office-administered specialty pharmaceuticals to a specialty pharmacy provider in a Medical Injectable Drug program.
Baldini CG; Culley EJ
J Manag Care Pharm; 2011; 17(1):51-9. PubMed ID: 21204590
[TBL] [Abstract][Full Text] [Related]
2. Effects of a physician office generic drug sampling system on generic dispensing ratios and drug costs in a large managed care organization.
Scott AB; Culley EJ; O'Donnell J
J Manag Care Pharm; 2007 Jun; 13(5):412-9. PubMed ID: 17605512
[TBL] [Abstract][Full Text] [Related]
3. Provider-administered drugs move to specialty pharmacy benefit.
Manag Care; 2014 Apr; 23(4):49. PubMed ID: 24864535
[No Abstract] [Full Text] [Related]
4. Five-year examination of utilization and drug cost outcomes associated with benefit design changes including reference pricing for proton pump inhibitors in a state employee health plan.
Johnson JT; Neill KK; Davis DA
J Manag Care Pharm; 2011 Apr; 17(3):200-12. PubMed ID: 21434697
[TBL] [Abstract][Full Text] [Related]
5. Case study of the effects of office-based generic drug sampling on antibiotic drug costs and first-line antibiotic prescribing ratios.
Conklin MH; Culley EJ; O'Donnell J
J Manag Care Pharm; 2009; 15(1):55-61. PubMed ID: 19125550
[TBL] [Abstract][Full Text] [Related]
6. Utilization, cost trends, and member cost-share for self-injectable multiple sclerosis drugs--pharmacy and medical benefit spending from 2004 through 2007.
Kunze AM; Gunderson BW; Gleason PP; Heaton AH; Johnson SV
J Manag Care Pharm; 2007; 13(9):799-806. PubMed ID: 18062731
[TBL] [Abstract][Full Text] [Related]
7. Utilization and cost of sildenafil in a large managed care organization with a quantity limit on sildenafil.
Cooke CE; Wong W; Lee H
J Manag Care Pharm; 2005 Oct; 11(8):674-80. PubMed ID: 16194131
[TBL] [Abstract][Full Text] [Related]
8. Managing the intersection of medical and pharmacy benefits.
McDonald RC
J Manag Care Pharm; 2008 May; 14(4 Suppl):S7-11. PubMed ID: 18507508
[TBL] [Abstract][Full Text] [Related]
9. Comparison of mail-order with community pharmacy in plan sponsor cost and member cost in two large pharmacy benefit plans.
Johnsrud M; Lawson KA; Shepherd MD
J Manag Care Pharm; 2007 Mar; 13(2):122-34. PubMed ID: 17330973
[TBL] [Abstract][Full Text] [Related]
10. Relationship of the use and costs of physician office visits and prescription drugs to travel distance and increases in member cost share.
Cecil WT; Barnes J; Shea T; Coulter SL
J Manag Care Pharm; 2006 Oct; 12(8):665-76. PubMed ID: 17269845
[TBL] [Abstract][Full Text] [Related]
11. Health plan approach to operationalizing a specialty drug management program.
Tegenu M
J Manag Care Pharm; 2008 May; 14(4 Suppl):S17-21. PubMed ID: 18507510
[TBL] [Abstract][Full Text] [Related]
12. AMCP Partnership Forum: What's Next for Specialty Medication Benefit Design and Reimbursement.
J Manag Care Spec Pharm; 2020 Oct; 26(10):1206-1213. PubMed ID: 32780612
[TBL] [Abstract][Full Text] [Related]
13. Effects of a step-therapy program for angiotensin receptor blockers on antihypertensive medication utilization patterns and cost of drug therapy.
Yokoyama K; Yang W; Preblick R; Frech-Tamas F
J Manag Care Pharm; 2007 Apr; 13(3):235-44. PubMed ID: 17407390
[TBL] [Abstract][Full Text] [Related]
14. Cost and utilization of behavioral health medications associated with rescission of an exemption for prior authorization for severe and persistent mental illness in the Vermont Medicaid Program.
Simeone JC; Marcoux RM; Quilliam BJ
J Manag Care Pharm; 2010 Jun; 16(5):317-28. PubMed ID: 20518584
[TBL] [Abstract][Full Text] [Related]
15. Specialty pharmacies and other restricted drug distribution systems: financial and safety considerations for patients and health-system pharmacists.
Kirschenbaum BE
Am J Health Syst Pharm; 2009 Dec; 66(24 Suppl 7):S13-20. PubMed ID: 19966075
[TBL] [Abstract][Full Text] [Related]
16. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years.
Barnett MJ; Frank J; Wehring H; Newland B; VonMuenster S; Kumbera P; Halterman T; Perry PJ
J Manag Care Pharm; 2009; 15(1):18-31. PubMed ID: 19125547
[TBL] [Abstract][Full Text] [Related]
17. Budgetary Impact of Cabazitaxel Use After Docetaxel Treatment for Metastatic Castration-Resistant Prostate Cancer.
Flannery K; Drea E; Hudspeth L; Corman S; Gao X; Xue M; Miao R
J Manag Care Spec Pharm; 2017 Apr; 23(4):416-426. PubMed ID: 28345444
[TBL] [Abstract][Full Text] [Related]
18. Formulary management in the Department of Defense.
Trice S; Devine J; Mistry H; Moore E; Linton A
J Manag Care Pharm; 2009 Mar; 15(2):133-46. PubMed ID: 19236127
[TBL] [Abstract][Full Text] [Related]
19. Community pharmacy and mail order cost and utilization for 90-day maintenance medication prescriptions.
Khandelwal N; Duncan I; Rubinstein E; Ahmed T; Pegus C
J Manag Care Pharm; 2012 Apr; 18(3):247-55. PubMed ID: 22468733
[TBL] [Abstract][Full Text] [Related]
20. Cost and Utilization Outcomes After Exclusion of Dipeptidyl Peptidase-4 Inhibitors and Other Diabetes Drug Category Changes in a Self-Funded, State Employee Managed Care Plan.
King J; McAdam-Marx C; McCaleb R; Davis D; Bemberg GB; Johnson JT
J Manag Care Spec Pharm; 2019 Jun; 25(6):646-651. PubMed ID: 31134855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]